ABSTRACT We have prospectively examined in 51 patients the relationship between the level of airway responsiveness to histamine and methacholine and the minimum medications required to control asthma. First we determined the least medication that was required to control symptoms so that they did not Non-allergic (non-specific) airway responsivenss to histamine and methacholine is increased in virtually all, if not all, subjects with current symptoms of asthma.' The degree of increase is related to the severity of symptoms,2 the number of previous hospital admissions,3 and the ease with which asthma is induced by non-allergic4-6 and allergic7 stimuli. Possibly also it may be related to treatment requirements.3 8 In a previous retrospective study we observed, in a group of asthmatics, a relationship between the level of airway responsiveness to histamine and the amount of treatment required to control symptoms. However there was a variation in responsiveness among patients requiring the same treatment.'
when there had been no respiratory infection or allergen exposure for six weeks, histamine and methacholine inhalation tests were carried out on separate days to determine the provocation concentration causing a fall in FEV1 of 20 % (PC20). There was a close correlation between the PC20 to the two agents. The patients were grouped into 1, those who required no medication; 2, those who required salbutamol (200 ,ug) occasionally but not daily; 3, those who required daily salbutamol; and 4, those who required additional beclomethasone dipropionate. The mean PC20 was highest in group 1 and lowest in group 4; there was a significant difference between each group. The results indicate that airway responsiveness to vasoactive amines is either an important determinant of the severity of asthma and the medication requirements or a consequence of the severity of asthma. They raise the possibility that measurement of responsiveness may be useful in some patients with established asthma to substantiate or question medication needs.
Non-allergic (non-specific) airway responsivenss to histamine and methacholine is increased in virtually all, if not all, subjects with current symptoms of asthma.' The degree of increase is related to the severity of symptoms,2 the number of previous hospital admissions,3 and the ease with which asthma is induced by non-allergic4-6 and allergic7 stimuli. Possibly also it may be related to treatment requirements.3 8 In a previous retrospective study we observed, in a group of asthmatics, a relationship between the level of airway responsiveness to histamine and the amount of treatment required to control symptoms. However there was a variation in responsiveness among patients requiring the same treatment.'
The objective of the present study was to treat a group of patients with asthma in a standard way to determine the minimum medication required to control symptoms and then to examine prospectively the relationship between the amount of treatment and airway responsiveness to histamine and methacholine. Factors known to influence responsiveness, such as airway calibre, recent respiratory infection, and allergen exposure were carefully controlled.
Methods
Fifty-one adults who were attending the Chest and Allergy Clinic at St Joseph's Hospital and who were under our care were studied (table). Their ages ranged from 15-70 years; 29 were female. All gave a history of episodic dyspnoea and wheezing consistent with the presence of asthma. All had previously had variability in forced expired volume in one second (FEV1) of greater than 20 % either spontaneously or after bronchodilator. All were non-smokers and none had features of other respiratory disease. Twenty-one were atopic as indicated by one or more wheal and flare skin respones to prick tests with 16 common allergen extracts. The extracts were of Alternaria tenuis, Hormodendrum, dog hair and tions were produced by the same Wright nebuliser which gave an output of 0-13 ml/min and a particle size of 1-5 Hm aerodynamic mass median diameter. A nose clip was worn and the aerosol was inhaled by tidal breathing for two minutes. An aerosol of normal saline was inhaled first, followed at fiveminute intervals by two-fold increasing concentrations of either histamine acid phosphate or methacholine (from 0-03 to 16 mg/ml). The FEV1 was measured before and at 0 5 and 1 5 min after each inhalation. Inhalations were discontinued when the FEV, had fallen 20% or more below the lowest post-saline value. The provocation concentration producing a fall in FEV1 of 20% (PC20) was read off the log-dose response curve by linear interpolation of the last two points. The relationship between the response to histamine and response to methacholine was determined using least squares regression analysis. Patients were grouped according to their minimum medication requirements into four groups: 1, those requiring no medication; 2, bronchodilator more than once per week but less than once per day; 3, bronchodilator daily; and 4, bronchodilator plus beclomethasone. There was a range in the PC20 of histamine and methacholine in individual patients in each treatment group (fig 1) . In patients with a PC20 >2 mg/ml symptoms of asthma were usually controlled on no medication or bronchodilator occasionally but not daily. Patients with a PC20 < 2 mg/ml generally required a daily bronchodilator + beclomethasone. The study has examined prospectively for the first time the relationship between non-allergic airway responsiveness and treatment requirements in asthma. There is evidence that in established asthma the level of hyperresponsiveness remains stable over long periods of time'0 unless heightened by exposure to respiratory infection,1' exposure to allergens '2 13 or to volatile chemicals'415 to which the person is sensitised or, possibly, by exposure to atmospheric pollutants such as oxides of nitrogen'6 and ozone. '7 In this study these exacerbating factors were excluded.
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